Lentiviruses infect both dividing and nondividing cells. In in pHP. The ability of this vector system to transduce dividthis study we characterized a lentiviral vector system coning and nondividing cell in vitro and in vivo was also demsisting of a packaging vector (pHP) and a transducing veconstrated. Compared with a Moloney murine leukemia tor (pTV) derived from a recombinant human immunodefivirus (MLV) vector, the HP/TV vectors transduced human ciency virus type 1 (HIV-1). In pHP, the long terminal muscle-, kidney-, liver-derived cell lines and CD34 + primary repeats (LTRs), the 5Ј untranslated leader and portions of hematopoietic progenitor cells more efficiently. Although the env and nef genes were deleted. The leader sequence the levels of the pTV transgene expression were high soon of pHP was substituted with a modified Rous sarcoma virus after transduction, the expression tended to decrease with (RSV) 59 bp leader containing a mutated RSV gag AUG time due either to the loss of proviral DNA or to the inactiand a functional 5Ј splice site. The pHP construct was vation of promoter activity, which was found to be cell typefound to direct Gag-Pol synthesis as efficiently as wild-type dependent. Analyses of extrachromosomal DNA showed HIV-1. The pTV construct contains sequences required for that the unintegrated proviral DNA of lentiviral vectors sur-RNA packaging, reverse transcription and integration, but vived much longer than that of the retroviral vectors. We lacks viral genes. Co-transfection of pHP, pTV and a vesdemonstrate that the HP/TV vector is capable of high icular stomatitis virus G (VSV-G) envelope plasmid proefficiency transduction and that long-term expression of duced vectors at titers of 10 5 -10 6 transducing units per lentiviral vectors is dependent on target cell type, the milliliter in 48 h. Replication-competent virus (RCV) was internal promoter and the transgene itself in the transducnot detected when deletions were made in the env gene ing vector.
Introduction
Efficient, long-term gene transfer is essential for clinical applications of gene therapy. Viral vectors are capable of efficiently transducing genes into target cells because they can bind host cell receptors and exert viral mechanisms for efficient gene expression. Retroviral vectors derived from MLV are well established and have been a useful tool for gene delivery. 1, 2 Other members of the retrovirus family, including HIV, human foamy virus (HFV) and feline immunodeficiency virus (FIV), have gained much attention recently in that infection of these viruses is not limited to actively dividing cells. [3] [4] [5] The restricted host cell tropism of lentiviruses such as HIV and FIV has been overcome by using alternative pseudotyping viral envelopes such as amphotropic MLV env or vesicular stomatitis virus G (VSV-G) glycoproteins. 6 Extensive studies of HIV have laid significant groundwork for the development of HIV-based lentiviral vectors. Shimada et al 7 have described a recombinant HIV-1-based gene transfer system that efficiently targets human CD4 + cells. This system consists of a packaging construct that expresses HIV-1 gag-pol and env genes and a transducing construct that expresses a reporter neo R gene. Using a three component vector system that included a third VSV-G envelope pseudotyping plasmid, Naldini et al 8 were able to expand the host cell types that could be targeted by HIV-1 vectors. Similar vector systems have recently been described that use HIV-2 and FIV constructs. 5, 9 The development of a useful lentiviral vector system must take into consideration basic lentiviral genetics and safety issues. For instance, while the amount of HIV sequence present in the vector is directly correlated with the risk of generating RCV, it is still not clear how much of the viral genome can be deleted during vector construction without adversely affecting the efficiency of the vector. 4 The first generation of lentiviral vectors should be constructed without any of the nonessential viral genes (eg accessory genes such as vif, vpr, vpu, nef) to reduce the risk of pathogenesis and without any sequences not required for vector functions (eg LTRs and env gene of the packaging vector constructs and gag-pol and env reading frames of the transducing vector constructs) to reduce the possibility of homologous recombination. Detailed mutational analyses of lentiviral genome will be necessary in order to determine what the minimal requirements are for an efficient and safe vector system.
To date, little information is available concerning the range of human cell types that can be efficiently and stably transduced by lentiviral vectors. In addition, the advantage of lentiviral vectors over conventional retroviral vectors has not been well characterized. To investigate these issues, we generated a recombinant HIV-1 vector system with multiple safety features based on a helper construct pHP and a transducing vector construct pTV. The possibility of producing replication competent virus (RCV) was carefully examined. The transduction efficiency of the HP/TV vector and a conventional MLV vector was studied using different human cell types including TE671 (muscle), 293T (kidney), HepG2 (liver), neuronal stem cells and primary CD34 hematopoietic progenitor cells and nonhuman primary rat neural and muscle cells. Transduction efficiency was assayed over short and long duration in tissue culture. The safety, expression kinetics, duration and integration status of this lentiviral HP/TV vector system are presented.
Results

Construction of recombinant HP/TV vectors
The two lentiviral constructs, pHP, which directs the synthesis of necessary viral proteins for virion assembly and pTV, which serves as a gene transducing vehicle for foreign gene delivery (see Figure 1) , were derived from a LTR-modified recombinant HIV-1 plasmid pNL4-3 with multiple modifications for safety reasons. 10 pHP-1 contains a recombinant cytomegalovirus immediate-early (CMV-IE) enhancer/promoter HIV-TAR element which replaces the 5Ј LTR of pNL4-3. The entire untranslated 5Ј leader sequence, nef, and the 3Ј LTR of pNL4-3 were also deleted in pHP-1 ( Figure 1a ). The HIV-1 5Ј untranslated leader sequence was replaced with a modified Rous sarcoma virus (RSV) 59 nt leader sequence containing a major splice donor site, a mutated RSV gag AUG and a preferred eukaryotic translation initiation sequence (-CCACCATG-) for the HIV-1 Gag synthesis (Figure 1c) . The nef gene in pNL4-3 was replaced by the bacterial gpt selective marker gene, and the 3Ј LTR was replaced by the SV40 polyadenylation signal. To prevent RCV production, the env gene was deleted by Bal31 exonuclease digestion at the NheI site. Two variants of env-deleted pHP-1 were generated and analyzed, pHP-1dl.2 (with a 2-nt deletion) and pHP-1dl.28 (with a 28-nt deletion). An alternative pHP construct, pHP-VSVG, was generated by inserting the VSV-G envelope gene between the env AUG and the NheI site in gp120 and introducing mutations in vpr, tat, and vpu ( Figure 1a) .
The transducing constructs (pTV) were made from pNL4-3 by deleting sequence extending from the middle of gag to the middle of env. A reporter gene cassette containing a heterologous enhancer/promoter directing a reporter gene was inserted in the nef region of the pTV vector as illustrated in Figure 1b .
Lentiviral vector production, transduction and RCV assay As safety is a major concern with HIV-derived vectors, the HP/TV vector system has been developed to minimize the possibility of homologous recombination and RCV production. To examine vector efficacy and RCV production, human rhabdomyosarcoma TE671 cells were co-transfected with the following three plasmids, a pHP construct, pHP-1 or pHP-VSVG, an envelope expression plasmid pHEF-VSVG and a pTV construct, pTV⌬SVneo, pTV⌬SVhyg, or pTV⌬CMV-nlacZ ( Figure 1 ). Since pHP-VSVG does not have a functional tat gene, a tat plasmid was also included when pHP-VSVG was tested. The resulting vector titer was determined by titration on TE671 cells using transfected culture supernatants. The reporter genes, neo, hyg and lacZ, were assayed by selecting resistant cell colonies using either G418, hygromycin B, or by colorimetric staining for ␤-galactosidase activity, respectively. For the detection of RCV, the transfected TE671 cells were co-cultured with MT4 cells, one of the most susceptible cell lines to HIV-1 NL4-3 infection. After co-cultivation, MT4 cells were monitored for syncytium formation and culture supernatant was subjected to HIV-1 reverse transcriptase (RT) assay. To increase the sensitivity of detecting RCV, fresh MT4 cells were added to the transfected culture weekly and 1 month after coculture, MT4 cells were fixed and immunostained using anti-HIV antibodies as described in Materials and methods. Results of this experiment are summarized in Table 1 . HP/TV co-transfection successfully produced viral vectors from all three pTV reporter constructs suggesting that the transducing vectors could be packaged into virus particles. However, RCV was detected in all transfected cultures except for pHP-VSVG. To generate RCV from co-transfections of pHP-1 and pTV⌬, at least two homologous genetic crossovers must occur, one in gag and the other in env. These results demonstrate that recombinant RCVs could arise from co-transfection of these vectors and that the co-culture and immunoassay provide a sensitive means for detecting RCVs.
Two nucleotide deletion in env prevents RCV production To improve the safety, the env gene was deleted in pHP and two deletion constructs were generated, pHP-1dl.2 and pHP-1dl.28. TE671 co-transfection was performed as described above. The wt HIV-1 plasmid pNL4-3 was included for comparison. RCV assay was performed as described above with incubation times extended to 60 days. The results of this experiment demonstrated that neither pHP-1dl.2, with a 2-nt deletion in env, nor pHP1dl.28, with a 28-nt deletion, generated detectable RCV ( Table 2 ). The 28 nt env deletion in pHP-1dl.28 did not negatively affect virus titer which was consistently greater than 10 5 transducing units/per milliliter of vector supernatant 24 h following transfection of either TE671 or 293T cells (Table 3) . To minimize the possibility of recovering env function, further deletions have been made in the env gene without affecting vector efficiency (unpublished).
RT and vector titer analyses of HP/TV versus wt HIV-1 To examine the pHP helper function and the pTV packaging efficiency, we first examined the viral reverse transcriptase (RT) production. HeLa cells were transfected with wt HIV NL4-3 , pHP-1, pHP-1dl.2, or pHP-1dl.28 and the culture supernatant was collected for RT assay 48 h later. Figure 2 shows that the levels of RT synthesis by the pHP-1-derived constructs were comparable to those observed for wt HIV-1; however, the vpr/tat-deleted pHP-VSVG produced only minute amounts of RT even when co-transfected with tat and vpr. Transfected cell lysates were also analyzed to see if the supernatant RT To compare helper function of pHP and wt HIV-1 further, TE671 or HeLa cells were co-transfected with a packaging vector (pHP-1, pHP-1dl.2 or wt pNL4-3), a transducing vector pTV⌬CMVnlacZ, and the envelope construct pHEF-VSVG. RT activity and vector titer were determined and summarized in Table 4 . The pHP packaging vectors produced RT at 30-40% of the wt level in TE671 cells but near wt level in HeLa cells. Interestingly, the vector titer assay indicated that HP/TV co-transfec- 
a Reporter genes neo r or hyg r of pTV⌬ were assayed by infecting HeLa cells with 50 l and 100 l of culture supernatant followed with G418 or hygromycin B selection 24 h after transduction, or for nlacZ reporter gene, by infecting HeLa cells with 20, 50 and 100 l of culture supernatant and stained with X-gal 48 h later as described in Materials and methods. pHP-1/pTV co-transfection produced Ͼ 10 3 /ml vector and pHP-VSVG/pTV produced Ͻ 10 2 /ml vector; however, the titer was not precisely determined due to the generation of RCV. b Replication-competent virus (RCV), assayed by co-culturing with MT4 cells for up to 30 days; RCV was detected by monitoring cytopathic effects on MT4 cells, RT and MAGI assays.
tions using either pHP-1 or pHP-1dl.2 produced two to three times more transducing units than the wt HIV NL4-3 /pTV co-transfection. The results of TE671 transfections further confirmed this observation (Table 5) . Packaging constructs pHP-1, pHP-1dl.2 and pHP-1dl.28 produced vector titers three to seven times higher than that of the wt construct HIV-1 . No RCV was detected from co-transfection of pTV with pHP-1dl.2 or pHP1dl.28 using our sensitive RCV assay. 
a The MT4 cells in the TE671/MT4 co-culture were transferred into a fresh MT4 culture on day 46 after co-culture and 12 days later, the MT4 cells were directly immunostained with anti-HIV antisera. b Results of rapid cell death and loss of MT4 cells, '+ to ++++' represent approximately 10 to 40% of the reporter CD4-HeLa cells which were HIV-positive after infection using 1 ml of supernatant; '−', no RCV was detected.
tors also efficiently transduced primary rat neuronal cultures ( Figure 3d , e, f) and human neuronal stem cellderived cultures ( Figure 3g , h, i), both were post-mitotic, terminally differentiated cells. These experiments demonstrate that HP/TV vectors efficiently transduce growtharrested or terminally differentiated nondividing cells. Interestingly, when human TE671 cells were transduced with high titer HP/TV vectors (pTV⌬EFGFP), differentiated muscle cells expressing GFP reporter gene was observed ( Figure 4 ). It is possible that the virion-associated Vpr was present at concentration high enough to induce differentiation of TE671 into muscle cells. Human CD34 hematopoietic progenitor cells are a slow-dividing cell population which is known to be difficult to transduce with conventional retroviral vectors. 
Short-and long-term analyses of lenti-versus retroviral transgene expression in human cells
The efficacy of gene therapy vectors is often judged by their transduction efficiency as well as long-term stability. To compare lentiviral and retroviral vectors directly, a long-term in vitro study was carried out. Three different human cell types, TE671, 293T and HepG2 cells, were transduced with either retroviral vector MFGnlacZ, that was produced from PA317 packaging cells and contained a MLV LTR-driven nlacZ gene, or lentiviral vector pTV⌬CMVnlacZ, that was generated from co-transfection with pHP-1dl.28 and contained a CMV-IE promoterdriven nlacZ gene. About 10 5 transducing units of vector (approximately 1 MOI) were used for each transduction in a total of three rounds of transduction. Transduced cultures were grown until confluent (3-5 days), trypsinized, counted and plated into six-well culture plates. Cells in T25 flasks were transfected with pHP DNA (12 g), pHEF-VSVG (7 g), pTV (12 g) and pCEP-tat (2 g) by calcium phosphate co-precipitation method and the culture supernatant was harvested 48 h later for p24 ELISA and vector titration assay on TE671 cells as described in Materials and methods. tu, transducing units. Twenty-four hours after plating, the cells were sampled for lacZ assay and the percentage of cells transduced was determined. The results of this short-term study showed that the lentiviral vectors transduced all three types of human cells three to 10 times more efficiently than did the MLV vectors (Table 6 ). For the long-term assays, the transduced cells were continuously propagated without selection. At different passage times, the percentage of nlacZ-expressing cells and the expression kinetics were determined ( Figure 6 ). The results showed that the stability of transgene expression varied as a function of cell type. Expression of the HP/TV vector, which was driven by the CMV-IE promoter, decreased with time in all three cell types, whereas MLV transgene expression gradually decreased in 293T cells but not in TE671 or HepG2 cells. To see if the presence of unintegrated proviral DNA in the short-and long-term cultures could explain the transient high expression phenotype of lentiviral vectors, a more sensitive assay was performed. Hirt DNA was harvested from early and late passages of cells transduced with either HIV or MLV vectors and analyzed by PCR using nested primers that specifically amplify one-or two-LTR unintegrated proviral DNA circles. One-LTR proviral DNA was detected in all three HP/TV vector transduced cultures from early passages (Figure 8a , TE671, 293T and HepG2 passage 3-5, lanes 3, 5 and 7, respectively) but not from late passages (passage 36-44, lanes 4, 6 and 8). Further amplification of the first round nested PCR products did not reveal the presence of lentiviral proviral DNA in the late passages of cells (not shown). In contrast, MLV proviral DNA was not detected either from early or from late passages of transduced TE671, HepG2 or 293T cells via a sensitive nested PCR assay using two sets of nested primers (passage 3-39 of MLV transduced cells, Figure 8b ).
Figure 2 RT and protein syntheses of HP/TV versus wt HIV-1. Expression of cell-free RT was measured in duplicate using supernatant of cultures transfected with packaging vectors as indicated. The insert Western analysis was performed using the same amounts of cell lysates from HIV-1 infected (MT4/NL4-3, lane 1) or transfected cultures (lanes 2 to 7). Protein molecular weight markers and the predicted sizes for HIV-1 gag p55 and p24 are indicated.
Discussion
The ability of lentiviruses to infect nondividing cells such as macrophages and neurons makes them good candidates for use as gene transfer tools. However, the complicated genome organization and regulation of viral gene expression, as well as the concerns of possible spread of AIDS with HIV-derived vectors, have hindered the wide dissemination of lentiviral vector technology. Using previously established attenuated HIV-1 constructs, 10, 11 we have successfully generated a recombinant lentiviral vector gene transfer system that is efficient and safe. Efficient synthesis of HIV-1 Gag-Pol requires Tat activation of LTR and the interaction of Rev-RRE to mediate nuclear export of mRNA, whereas the accessory gene functions of vif, vpr, vpu and nef have been shown to be dispensable for viral replication, as well as for vector function in tissue culture. 12, 13 Both tat and rev genes are functional in the gag-pol packaging construct pHP. In pHP, several ciselements essential to viral replication have been deleted, including both the 5Ј and the 3Ј LTRs, the 3Ј PPT and the entire 5Ј leader sequences except for TAR. A 59 nt artificial RSV splice donor sequence has been inserted into pHP to support tat and rev mRNA splicing. As illustrated in Figure 1c , the RSV gag AUG is located in the 59 nt artificial leader sequence 5Ј to the RSV SD site. To prevent interference with the use of the downstream HIV gag AUG, the RSV gag AUG was mutated in pHP. Although it is not clear if mutation of the RSV gag AUG could affect the RSV SD function, the expression of functional tat and rev genes by pHP suggests that it did not affect the vector function.
Compared with wt HIV-1, the changes made in pHP had little effect on viral RT synthesis, nor did it diminish the vector titer. Interestingly, although wt HIV-1 exhibited higher RT activity than pHP when co-transfected with a pTV vector, wt HIV-1 produced fewer infectious vectors than pHP, possibly due to the interference of wt genome with vector genome packaging. In fact, the HP/TV vector system consistently produced three to five times more vector than did the wt HIV/TV co-transfections. Western blot analyses showed that HP produced Gag at levels similar to that of wild-type HIV-1. This result is consistent with the results of our previous studies in which we found that the CMV-TAR chimeric promoter exhibits high transcriptional activity and remains Tat responsive. 14 We examined RCV production via recombination of HP/TV by testing env-deleted HP constructs in co-transfection experiments. By coupling the co-culture method with immunostaining, we were able to detect very low amounts of RCV. Using this assay, RCV was easily detected in cultures co-transfected with the original pHP- 
Figure 4 Lentiviral transduction and differentiation of human rhabdomyosarcoma cells. Human TE671 cells were transduced with lentiviral vector pTV⌬EFGFP three times (3-5 MOI) and incubated for 4-5 days. The GFP gene expression was detected directly under a Zeiss Axiovert 25 inverted fluorescent microscope with ×10 Fluar objective lens (Carl Zeiss, Thornwood, NY, USA). (a and c) phast-contrast photographs (10 × 10); (b and d) green fluorescent cells corresponding to a and c.
1 construct which contains a wild type env gene, but not in cultures co-transfected with pHP-1dl.2 which has a 2-nt deletion between the C5 and the C6 domains of env gp120. The absence of RCV production in these cultures was likely due to the lack of env function rather than the lack of recombination because a recombinant virus lacking nef, but containing a reporter gene, could still be generated via a double genetic crossover between pHP and pTV. Additional mutations had been introduced in pHP and pTV to eliminate homologous recombination which effectively eliminated the possibility of RCV production (Cui et al and Iwakuma et al, submitted). In a previous study, the transduction efficiencies of an HIV-1-based vector and an MLV-based vector have been compared in both proliferating and growth-arrested HeLa cells and 208F rat fibroblasts. The results show that the HIV-based vectors infect G1/S and G2 arrested HeLa cells and G0 arrested 208F cells more efficiently than the MLV-based vector. 8 In this study, we showed that the HP/TV vector transduced growth-arrested, terminally differentiated or slow-dividing cells efficiently. We have also demonstrated efficient transgene expression in vivo in rat muscles after injection with the HP/TV vectors. Retroviral vectors failed to transduce these cell types. In addition, we tested three different human cell lines, TE671, 293T and HepG2 and compared short-term and long-term transduction using both an HIV-1-based HP/TV vector and an MLV-based MFG vector. Again, our results showed that the HP/TV vector expressed the bacterial nlacZ transgene at higher efficiencies than the MFG vector in all three cell lines, but that expression of the lentivirally transduced nlacZ gene gradually decreased after multiple passages. After more than 35 passages, the expression level of the HP/TV nlacZ transgene was similar to that observed for the MLV nlacZ transgene. Southern analyses of TE671 genomic DNA suggested that the HP/TV nlacZ transgene was integrated into the target cells, but was lost from the cultures upon repeated passages. Southern analyses of 293T and HepG2 genomic DNA indicated that the transgene was still present in these cells even after 49 passages, a result suggesting that the decrease of HP/TV nlacZ transgene expression may have been due to loss of promoter activity.
Hirt DNA analyses indicated that unintegrated lentiviral proviral DNA could persist in transduced cells for more than four to five passages, but that after 40 passages it could not be detected in any of the three cell types examined. In contrast, no MLV-derived unintegrated proviral DNA was detected as early as passage 3 in all the cell types examined. Together, these data suggest that lentiviral vectors are more efficient than MLV vectors possibly attributable to the prolonged presence of unintegrated lentiviral proviral DNA that may drive lentiviral transgene expression. Stevenson et al 15 reported that unintegrated HIV-1 DNA can serve as a template for HIV-1 antigen synthesis, whereas Sakai et al 16 reported opposite results with an HIV-1 integrase mutant. Our data show that high level lentiviral vector transgene expression coincides with the presence of unintegrated proviral DNA which is consistent with Stevenson's observation. It is conceivable that the internal CMV-IE promoter in the unintegrated HP/TV proviral DNA is active but the 5Ј LTR promoter is not because the latter requires Tat transactivation.
We have observed differentiation of TE671 cells into muscle cells after transduction with vpr+ but not with vpr− HP/TV vectors ( Figure 4 and data not shown). Thus, it is also possible that the loss of integrated pTV gene in TE671 culture was due to the disappearance of transduced and differentiated TE671 cells with time. On the other hand, pTV contains a CMV-IE enhancer/promoter which has been shown to be inactivated frequently after integration. 17, 18 Promoter inactivation could therefore have contributed to loss of HP/TV gene expression. Interestingly, in a separate study, we observed increased transgene expression with time, even after passage 30, in TE671 cells transduced with lentiviral vector carrying a human growth hormone gene under control of different internal promoters, CMV-IE and human elongation factor 1␣ promoters (Iwakuma and Chang, unpublished). Thus, the expression phenotype of a transgene is strongly influenced by the characteristics of the transduced cell, the internal promoter as well as the transgene itself. Current research efforts are directed toward further modification of the HP/TV vector system to improve both the safety and the long-term efficacy of this lentiviral vector system.
Materials and methods
Cells and animals
HeLa (human cervical carcinoma) and HepG2 (human hepatoma) cells were obtained from ATCC (Rockville, MD, USA). TE671 (human rhabdomyosarcoma) and 293T (transformed human primary embryonal kidney) cells were kindly provided by Dr Takeuchi (Chester Beatty Laboratories, obtained from ECACC, UK) and Dr H Goldstein (Albert Einstein College of Medicine, NY, USA), respectively. All cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Gibco Canada), penicillin and streptomycin, and mycoplasma contamination was monitored periodically and eliminated if found. 19 Sprague-Dawley rats (180-200 g of body weight) were purchased from the Health Science and Laboratory Animal Service (HSLAS) at the University of Alberta. The HP/TV vector system has gone through extensive RCV testing and has been approved for use in a biosafety level II laboratory employing a level III standard operating protocol. The level III protocol was approved by the Biosafety Committees of the University of Alberta and the University of Florida. The lentiviral vector tissue culture and animal studies were performed in a level II+/III laboratory using protocols approved by the Animal Welfare Committees and the Biosafety Committees at the University of Alberta and at the University of Florida.
Plasmid construction pHP-1 was generated as follows. First, a recombinant enhancer/promoter CMV-TATA-TAR fragment was isolated from dl.kB/Sp1-CMV-TATA-TAR HIV 11 by BbrpIHindIII digestion. This fragment was cloned into the EcoRV-BamHI site of pSP72 (Promega, Madison, WI, USA) using a linker possessing HindIII and BamHI cohesive sites. The pSP72 vector contains a modified gag AUG located within a favored eukaryotic translation initiation sequence context (-CCACCATG-), and a major splice donor site derived from Rous sarcoma virus (RSV) containing a mutated RSV gag AUG. 20 The linkers used in this construct were created by annealing the following oligonucleotides: 5Ј-AGC TTG GTC GCC CGG TGG ATC AAG ACC GGT AGC CGT CAT AAA GGT GAT TTC GTC G-3Ј and 5Ј-GAT CCG ACG AAA TCA CCT TTA TGA CGG CTA CCG GTC TTG ATC CAC CGG GCG ACC A-3Ј. Secondly, the gag coding sequence for the pHP-1 construct was amplified from the HIV-1 molecular clone pNL4-3 using PCR and the following primers which encompass the gag gene: sense, 5Ј-CGG GAT CCA CCA TGG GTG CGA GAG CGT C; antisense, 5Ј-ATC CTA TTT GTT CCT GAA GG. The PCR product was digested with BamHI-SphI and ligated to the chimeric CMV-TAR promoter. Thirdly, a subclone of pHP-dl.pA without the polyadenylation signal was made by ligating together the 1112 bp HpaI-SphI fragment isolated from the chimeric CMV-TAR-gag construct, the 7922 bp SphIXhoI fragment isolated from pNLgpt and a plasmid vector backbone obtained by digesting pBS-KS(−) (Stratagene, La Jolla, CA, USA) with EcoRV and XhoI. pNLgpt was generated by cloning the E. coli xanthineguanine phosphoribosyltransferase (gpt) gene from pMSG (Pharmacia, Uppsala, Sweden) into the nef open reading frame (ORF) of pNL4-3 between the nef AUG and the XhoI site. Finally, pHP-1 was generated by ligating a 422 bp XhoI-PstI digested SV40 polyadenylation signal obtained from pREP9 (Invitrogen, Carlsbad, CA, USA) into pHP-dl.pA.
The pHP-VSVG vector was generated by ligating the following four DNA fragments together: (1) the NotIEcoRI fragment of pHP-1 containing the chimeric CMV-TATA-TAR-gag-pol sequence; (2) a fragment generated from HIV-1 possessing a deletion in vpr and tat that was introduced by PCR mutagenesis using the primers, sense-TAA GAA TTC TAG TAG GTT GCT TTC ATT GCC and antisense-CTT CTC CTT CAV TCT CGA GTG ATC ACT GTC TTC TGC TCT TTC-(encompassing env AUG where a new XhoI and a BclI site were created) as previously described; 10 (3) a SalI-XbaI VSV-G gene fragment obtained from pBS-VSV-G (kindly provided by Tom Hobman at University of Alberta); and (4) the NheI-NotI fragment of pHP-1 containing the 3Ј env gp120-gpt-SVpA and plasmid backbone. The differences between the final pHP-VSVG construct and the pHP-1 vector are that the region between the 3Ј end of the vpr coding region and the 5Ј end of the tat first exon has been deleted and a portion of the HIV-1 gp120 env gene has been substituted with VSV-G gene in the pHP-VSVG construct.
To generate the env-deleted pHP-1 constructs, pHP-1 was digested with NheI and treated with Bal31 exonuclease for 1, 2 or 5 min. The digest products were self-ligated following treatment with T4 DNA polymerase. Competent E. coli DH5␣ were transformed with the self-ligated plasmid DNA and from a pool of more than 48 deletion mutants, two clones (pHP-1dl.2 and pHP-1dl.28) were selected, sequenced and used in this study.
pTV⌬SVneo and pTV⌬SVhyg were generated by delet- ing gag-pol and env sequences starting from the SpeI site in the middle of the gag ORF extending to the NheI site in the middle of the env ORF of pNLSVneo and pNLSVhyg, respectively. pNLSVneo and pNLSVhyg were generated by inserting a SV40 promoter-driven neomycin-or hygromycin B-resistant gene between the nef AUG, where a HindIII site had been generated by site-specific mutagenesis and the unique XhoI site in nef in pNL4-3. pTV⌬CMVnlacZ was made by inserting a SalI-KpnI digested CMV-nlacZ fragment, derived from pcDNA3-nlacZ, into XhoI-KpnI digested pTV⌬SVneo. The nuclear lacZ gene was generated by fusing a nuclear localization signal of SV40 large T antigen to the N-terminus of the bacterial lacZ gene that was obtained from the pBlueBacHisA vector (Invitrogen) using PCR mutagenesis. The oligonucleotide primer 5Ј-CCC GGG TCT AGA AGC TTC CAC CAT GCC TAA GAA GAA ACG AAA GAT CGA TCC CGT CGT TTT ACA ACG TCG-3Ј, which contains a favored eukaryotic translation initiation codon (underlined), was used in the PCR procedure. pTV⌬EFGFP was generated by replacing the CMVnlacZ gene of pTV⌬CMVnlacZ with the human elongation factor 1␣ promoter of pHEF kindly provided by D Denny plus a GFP reporter gene. pTV⌬EFnlacZ was then made by replacing the GFP gene of pTV⌬EFGFP with nlacZ gene. The VSV-G envelope expression plasmid pHEF-VSVG was constructed by inserting a PCR-amplified VSV-G fragment containing a favored translational initiation codon into the EcoRI site of pHEF. The mutagenesis site and flanking sequences of all the constructs were confirmed by DNA sequencing.
DNA transfection
The MLV-derived vectors were generated by transfecting the packaging cell line PA317 with pMFGnlacZ which contains the same recombinant nlacZ gene as the one cloned into pTV⌬CMVnlacZ. The HP/TV vectors were generated by co-transfecting HeLa or TE671 cells with the pHP, pTV and pHEF-VSVG plasmids. A modified calcium phosphate DNA transfection protocol was performed as previously described. 10 The transfection efficiency, normally ranging from 50 to 90%, was determined by X-gal staining or by a radioimmunoassay for human growth hormone when the XGH5 plasmid was included in the transfection procedure (Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). The transfected cells normally produce retro-or lentiviral vectors with titers ranging from 10 5 -10 6 transducing units (tu) per ml. The VSV-G pseudotyped vectors were routinely concentrated 30-50 times by centrifugation in a table-top microfuge (21 000 g) for 2.5-3 h at room temperature and resuspended by vortexing in a thermomixer at room temperature for 2-3 h.
Vector transduction and titration
Virus supernatants were harvested 24, 48 and 72 h following addition of DNA by low speed centrifugation (1200 g for 5 min) or by filtration using a 0.45 m lowprotein binding filter to remove cell debris from transfected culture. No reduction in titer was observed between 24-48 h, but a one-log reduction in titer was frequently observed in harvests carried out at 72 h. The supernatants were aliquoted and stored at −80°C until use. Retroviral vector was titered on HeLa or TE671 cells and lentiviral vector was titrated on mitomycin-C-treated TE671 cells (5 g/ml for 2.5 h). To titer the vector, cells were infected with diluted virus stocks at low MOI in a small volume of growth medium containing polybrene (8 g/ml). Cultures were grown for 3-4 h, supplemented with additional growth medium and then incubated for a final period of 48 h before staining. At least two different dilutions were examined for each titration sample. To detect the transduced cells, the culture was washed twice with phosphate buffered saline (PBS) and fixed at room temperature with 1% formaldehyde and 0.2% glutaraldehyde (Sigma, St Louis, MO, USA) in PBS for 5 min.
After three more washes with PBS, the cells were incubated at 37°C in PBS or distilled water containing 4 mm K-ferrocyanide, 4 mm K-ferricyanide, 2 mm MgCl 2 and 0.4 mg/ml X-gal overnight. The CD34-derived cell colonies were stained under similar condition with a modified X-gal solution with adjusted pH at 8.5 to eliminate background mammalian ␤-galactosidase activity. The transduced cells stained with X-gal were examined with an inverted microscope. The high background ␤-galactosidase activity in HepG2 cells, primary cultures and tissues can also be eliminated by increasing the pH of the incubation buffer.
Mitomycin-C treatment
To arrest cell cycle, TE671 or HeLa cells were treated with mitomycin-C at 10 g/ml for 4 h, trypsinized and plated into a six-well culture plate. Cell cycle arrest was monitored by propidium iodide staining and FACS analysis. The cells were transduced with HP-TV nlacZ vector in the presence of 8 g/ml polybrene in a volume of 0.5 ml for 2-3 h and fed with growth media. After 48 h, the nuclear lacZ expression was detected by X-gal staining as described above.
Primary culture and in vivo transduction
The rat neuronal cells, kindly provided by Dr Campenot from University of Alberta, were isolated from rat brains according to the protocol of Ure et al, 21 and grown in culture media containing 10 m cytosine arabinoside (Sigma) which inhibited cell proliferation. The human neurons and astrocytes were obtained from differentiated embryonic neural stem cells prepared and provided by Dr M Arcellana-Panlilio at Neurospheres (Calgary, Alberta, Canada). These cells were infected with the HP-TV vectors carrying the nlacZ reporter gene as described above. Briefly, cells were incubated in culture media containing the HP-TV vector. After a 2 h incubation, conditioned media (from cultured cells) was added to the cultures and they were incubated for an additional 5-day period. Following incubation, the infected cells were fixed and processed for X-gal staining as described above. In vivo transduction of rat muscle was performed using a 25-gauge insulin syringe. pTV⌬CMVnlacZ vector, 2-5 × 10 5 tu/ml, was prepared from transfected TE671 and used for intramuscular injection. Each injection site received 200 l of unconcentrated vector or 20 l of 30-50 × concentrated vector.
Human CD34 cells were obtained from human bone marrow or mobilized peripheral blood cells collected after obtained informed consent from patients treated with G-CSF to mobilize bone marrow derived CD34 + cells. Enrichment for CD34
+ cells was performed using an anti-CD34 antibody affinity column (CellPro, Bothel, WA, USA). The CD34 + cells were washed two to three times with RPMI medium containing 10% FBS and resuspended in RPMI + 10% FBX supplemented with 50 ng/ml human flt3 ligand, 50 ng/ml human c-kit ligand and 50 ng/ml human IL-3 at 1-5 × 10 5 cells per 100 l. The CD34 + cells was transduced two to three times with pTV vectors containing the nlacZ or GFP reporter genes with 8 g/ml polybrene for 3-4 h each time. The transduced CD34 + cells were maintained in RPMI medium supplemented with growth factors for 1-4 days before they were plated in semi-solid methylcellulose colony assay. After 2-3 weeks in culture, the expression of transduced nlacZ or GFP genes was assayed by X-gal colorimetric staining or observed under an inverted fluorescent microscope.
RT assay and p24 ELISA RT assay was performed as previously described.
11 p24 ELISA was performed using reagent kits purchased from SAIC (Frederick, MD, USA) and the protocols provided therein.
RCV assay
Assays for the detection of RCV included: (1) co-cultivation with a sensitive cell line such as MT4, AA2 or PBLs; (2) MAGI cell assay which relies on Tat transactivation of an integrated LTR-nlacZ gene in HeLaCD4 cells; 22 and (3) immunohistochemical staining for the detection of Gag p24 antigen expression at single cell level. 10 In the long-term co-culture RCV assay, MT4 cells were added to the HP/TV transfected cells 48 h after transfection. Fresh medium was added to the cultures every 3 days at which time two-thirds of the culture media was discarded. Fresh MT4 cells were added to the cultures once a week. Syncytium formation was observed under an inverted microscope. At different time-points, MT4 cells in the co-culture were collected and immunostained using a monoclonal anti-p24 antibody for the detection of HIV-1 Gag antigen as described previously. 10 Genomic and Hirt DNA preparation and Southern and PCR analyses A modified protocol was used which allowed simultaneous preparation of genomic and Hirt DNA. 23 Briefly, cells were washed three times with PBS and resuspended in 250 l 25 mm Tris-HCl pH 8.0 buffer containing 50 mm glucose and 10 mm EDTA. The resuspended cells were incubated at room temperature for 5 min and then lysed in 200 l lysis buffer containing 200 mm NaOH and 1% SDS on ice for 5 min. The lysate was neutralized by adding 150 l potassium acetate (5 m, pH 4.8). Cell debris and chromosomal DNA (in pellet) were removed by centrifugation at 10 000 g for 5 min. The supernatant containing the Hirt DNA was loaded on to a QIAprep Spin Column (Qiagen, Santa Clarita, CA, USA) and centrifuged for 1 min. Columns were washed to remove residual endonucleases and salts, and the DNA was eluted with 100 l distilled water (75°C) by centrifugation at 10 000 g for 1 min. The pellet containing the genomic DNA was processed using a Qiagen genomic DNA harvesting kit starting from the proteinase digestion step according to the manufacturer's instructions.
Southern analysis was performed using standard protocols as described by Maniatis et al 24 and a modified hybridization procedure as described previously. 10 PCR analysis of unintegrated lentiviral proviral DNA was performed using the following two sets of nested primers flanking the LTR of the circular lentiviral proviral DNA: sense -CG ACT CCT GGA GCC CG-(3Ј end of the lacZ gene) and sense -ACA AGG CAG CTG TAG ATC TTA GCC-(5Ј end of poly-purine tract (PPT) of HIV-1); antisense -ACT TTC GCT TTC AAG TCC C-(upstream of primer binding site) and antisense -ACT GAC GCT CTC GCA CCC AT-(downstream of gag AUG). The amplified products from the one-LTR lentiviral proviral circular DNA will be 715 bp and from the two-LTR proviral circular DNA will be 1351 bp. For the detection of uninte-grated MLV proviral DNA, we used the following two sets of nested primers flanking the LTR of the circular MLV priviral DNA: sense -AAC CAG CCA TCG CCA TC-(3Ј of lacZ), sense -ACG ACT CCT GGA GCC CG-(3Ј of lacZ) or sense -AAA AGA TTT TAT TTA GTC TCC AG-(5Ј end of PPT of MLV); sense ACT AGA CAA TCG GAC AGA C-(downstream of U5) and sense -TCG TCT CCT ACC AGA ACC-(downstream of U5). The amplified products from the one-LTR MLV proviral DNA will be 733 bp or 1195 bp. Two-LTR circles were infrequently amplified from both HIV and MLV vector transduced cells.
